Antimicrobial Peptides
By A. A. Bahar, D. Ren. Pharmaceuticals, 2013
2,206 citations recorded by the source corpus.
The rapid increase in drug-resistant infections has presented a serious challenge to antimicrobial therapies. The failure of the most potent antibiotics to kill “superbugs” emphasizes the urgent need to develop other control agents. Here we review the history and new development of antimicrobial peptides (AMPs), a growing class of natural and synthetic peptides with a wide spectrum of targets including viruses, bacteria, fungi, and parasites. We summarize the major types of AMPs, their modes of action, and the common mechanisms of AMP resistance. In addition, we discuss the principles for designing effective AMPs and the potential of using AMPs to control biofilms (multicellular structures of bacteria embedded in extracellular matrixes) and persister cells (dormant phenotypic variants of bacterial cells that are highly tolerant to antibiotics).
Subfields: Food Science, Microbiology, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/726d389f49a30e7a99c9c8c84d1645597f7307ea
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Food Science
In Microbiology
In Molecular Biology
- Alexandra R. Fernandes
- Brian W. Kwan
- Ji-Hong Hong
- James Y. Zou
- Q. Kong
- Yuchen Huan
- Anvita Gupta
- Lúcia Santos
Citations in the corpus
- Mechanisms of Cellular Uptake of Cell-Penetrating Peptides (2011, background): “AMPs also consist of short sequences of cationic and hydrophobic peptides [76, 77].”
- A Comprehensive Review on Current Advances in Peptide Drug Development and Design (2019, background): “The highly amphipathic and cationic characteristics of antimicrobial peptides (AMPs), for example, have allowed them to penetrate cell membranes to eliminate microbes and infectives by modulating immune responses [43].”
- Feedback GAN (FBGAN) for DNA: a Novel Feedback-Loop Architecture for Optimizing Protein Functions (2018, background): “GN ] 5 A p r 2018 weight peptides with broad antimicrobial activity against bacteria, viruses, and fungi [12].”
- Degradation and removal methods of antibiotics from aqueous matrices--a review. (2011, background): “…structure (Marzo and Bo, 1998; Bannister, 2000; Lindner et al., 2000; McGregor, 2000; Ponsford, 2000; Roberts, 2000; Southgate and Osborne, 2000; Cavalleri and Parenti, 2001; Kirst, 2001; Mor, 2001; Kadow et al., 2002; Brimble, 2003; WeidnerWells and Macielag, 2003; Sum, 2004; Ohno et al., 2010).”
- Strategies for combating bacterial biofilms: A focus on anti-biofilm agents and their mechanisms of action (2017, background): “bilayer as well as solubilizing in aquatic environment.(176) Antimicrobial peptides usually bind electro-”
- Antimicrobial Peptides: Classification, Design, Application and Research Progress in Multiple Fields (2020, positive): “Enterocin AS-48 is an AMP used to preserve cider, fruit and vegetable juices, and enterocin CCM4231 is used to preserve soy milk (Rai et al., 2016; Santos et al., 2018).”
- The antimicrobial peptides and their potential clinical applications. (2019, background): “Various antibiotics have broadly been applied to treat human infectious diseases since the first antibiotic Penicillin was discovered by Alexander Fleming in 1928 [1, 2].”
- Bacterial Persister Cell Formation and Dormancy (2013, background): “Antimicrobial peptides do not function like traditional antibiotics, which disrupt cellular processes, but rather act by directly disrupting cell structure, with activity against bacteria, viruses, and fungi (56).”
- Nano-Strategies to Fight Multidrug Resistant Bacteria—“A Battle of the Titans” (2018, background): “In mammals, they are an innate host defense mechanism against pathogens (Bahar and Ren, 2013).”
- Biofilms as Promoters of Bacterial Antibiotic Resistance and Tolerance (2020, background): “They disrupt bacterial membranes through either one of three different mechanisms, (i) detergent-like membrane packing disruption, (ii) formation of pores in the barrel-stave model and (iii) toroidalpore model [299].”
- Docking small peptides remains a great challenge: an assessment using AutoDock Vina (2015, background): “Peptides also appear at different points in the immune response: in the form of epitopes recognized by e.g. antibodies and presented by antigen-presenting cells, as complementarity determining regions in antibody binding loops, and as antimicrobial peptides [3, 4].”